TP53 and cancer: Finally, it has been demonstrated that UCB may easily cross cell membranes in vivo, infiltrate colon cancer cells to stop tumor cell growth [179], trigger death in cancer cells in vitro [180], and control gene transcription (via ERK, p53, and p27) [181].